Market Research Logo

Drugs of Abuse / Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018

Drugs of Abuse / Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Drugs of Abuse / Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018 provides an overview of Drugs of Abuse / Toxicology Rapid Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drugs of Abuse / Toxicology Rapid Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Drugs of Abuse / Toxicology Rapid Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drugs of Abuse / Toxicology Rapid Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drugs of Abuse / Toxicology Rapid Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Drugs of Abuse / Toxicology Rapid Tests Overview
3 Products under Development
3.1 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Stage of Development
3.2 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Territory
3.3 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Regulatory Path
3.4 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Estimated Approval Date
4 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products under Development by Companies
4.1 Drugs of Abuse / Toxicology Rapid Tests Companies - Pipeline Products by Stage of Development
4.2 Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Stage of Development
5 Drugs of Abuse / Toxicology Rapid Tests Companies and Product Overview
5.1 American Bio Medica Corp Company Overview
5.1.1 American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Behavioral Diagnostics Inc Company Overview
5.2.1 Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bio-Alternative Medical Devices Ltd Company Overview
5.3.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 BioMedomics Inc Company Overview
5.4.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biosensia Ltd Company Overview
5.5.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Dimerix Ltd Company Overview
5.6.1 Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Group K Diagnostics Company Overview
5.7.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.8 ImmunoScience Inc Company Overview
5.8.1 ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Quidel Corp Company Overview
5.9.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Rapid Pathogen Screening Inc Company Overview
5.10.1 Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Seacoast Science, Inc. Company Overview
5.11.1 Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 The University of South Australia Company Overview
5.12.1 The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview
5.13 Thermo Fisher Scientific Inc Company Overview
5.13.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 True Diagnostics Inc Company Overview
5.14.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Drugs of Abuse / Toxicology Rapid Tests- Recent Developments
6.1 May 14, 2018: ABMC Reports First Quarter 2018 Results
6.2 Apr 27, 2018: Dimerix: Quarterly Review - Q3 FY2018
6.3 Feb 28, 2018: ALFA receives another US FDA 510(k) clearance for Simple Cup multi-drug test with Driven Flow
6.4 Nov 14, 2017: ABMC Reports Third Quarter 2017 Results
6.5 Aug 16, 2017: FDA Grants OTC Clearance for ABMC’s Rapid TOX CUP II
6.6 Aug 14, 2017: ABMC Reports Second Quarter 2017 Results
6.7 Jul 19, 2017: Alere Launches Alere iCup Rx Drug Screen For Detecting Commonly Misused And Abused Prescription Drugs
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Stage of Development
Table 2: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Territory
Table 3: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Regulatory Path
Table 4: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Estimated Approval Date
Table 5: Drugs of Abuse / Toxicology Rapid Tests Companies - Pipeline Products by Stage of Development
Table 6: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Stage of Development
Table 7: American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Rapid Drug Screen - Nicotine - Product Status
Table 9: Rapid Drug Screen - Nicotine - Product Description
Table 10: Rapid ONE - Nicotine - Product Status
Table 11: Rapid ONE - Nicotine - Product Description
Table 12: Rapid TOX Cup II - CLIA - Product Status
Table 13: Rapid TOX Cup II - CLIA - Product Description
Table 14: Rapid TOX Cup II - Nicotine - Product Status
Table 15: Rapid TOX Cup II - Nicotine - Product Description
Table 16: RDS InCup - Nicotine - Product Status
Table 17: RDS InCup - Nicotine - Product Description
Table 18: Behavioral Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Epigenetic Alcohol Test - Product Status
Table 20: Epigenetic Alcohol Test - Product Description
Table 21: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Digital Strip Reader - Drugs Of Abuse - Product Status
Table 23: Digital Strip Reader - Drugs Of Abuse - Product Description
Table 24: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Rapid Drug Overdose Test - Cocaine - Product Status
Table 26: Rapid Drug Overdose Test - Cocaine - Product Description
Table 27: Rapid Drug Overdose Test - Morphine - Product Status
Table 28: Rapid Drug Overdose Test - Morphine - Product Description
Table 29: Rapid Quantitative Acetaminophen Detection Assay - Product Status
Table 30: Rapid Quantitative Acetaminophen Detection Assay - Product Description
Table 31: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 32: RapiPlex - Drugs Of Abuse Assay - Product Status
Table 33: RapiPlex - Drugs Of Abuse Assay - Product Description
Table 34: Dimerix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: VisuaLine Multi Dip Panel - Product Status
Table 36: VisuaLine Multi Dip Panel - Product Description
Table 37: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Multidiagnostic - Aflatoxin B1 Test - Product Status
Table 39: Multidiagnostic - Aflatoxin B1 Test - Product Description
Table 40: Multidiagnostic - Heavy Metals Test - Product Status
Table 41: Multidiagnostic - Heavy Metals Test - Product Description
Table 42: Multidiagnostic - Paraoxon Test - Product Status
Table 43: Multidiagnostic - Paraoxon Test - Product Description
Table 44: Multidiagnostic - Pentachlorophenol (PCP) Test - Product Status
Table 45: Multidiagnostic - Pentachlorophenol (PCP) Test - Product Description
Table 46: ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Salivax - Drug Of Abuse - Product Status
Table 48: Salivax - Drug Of Abuse - Product Description
Table 49: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Sofia - Toxicology Assay - Product Status
Table 51: Sofia - Toxicology Assay - Product Description
Table 52: Triage - Toxicology Assay - Product Status
Table 53: Triage - Toxicology Assay - Product Description
Table 54: Rapid Pathogen Screening Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: OrganoTox - Product Status
Table 56: OrganoTox - Product Description
Table 57: Seacoast Science, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Point-Of-Care Drug Screen Test - Product Status
Table 59: Point-Of-Care Drug Screen Test - Product Description
Table 60: The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Point-Of-Care Test - Drug Of Abuse - Product Status
Table 62: Point-Of-Care Test - Drug Of Abuse - Product Description
Table 63: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Point-Of-Care Platform - Drugs Of Abuse Assay - Product Status
Table 65: Point-Of-Care Platform - Drugs Of Abuse Assay - Product Description
Table 66: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: TrueDX - Drug Of Abuse Test - Product Status
Table 68: TrueDX - Drug Of Abuse Test - Product Description
Table 69: Glossary
1.2 List of Figures
Figure 1: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Stage of Development
Figure 2: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Territory
Figure 3: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Regulatory Path
Figure 4: Drugs of Abuse / Toxicology Rapid Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report